Chancellor Financial Group WB’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.1M Buy
918
+15
+2% +$15.3K 0.68% 31
2026
Q1
$831K Sell
903
-25
-3% -$25.3K 0.59% 39
2025
Q4
$997K Hold
928
0.68% 31
2025
Q3
$708K Sell
928
-125
-12% -$93K 0.5% 42
2025
Q2
$821K Hold
1,053
0.63% 37
2025
Q1
$870K Sell
1,053
-35
-3% -$29.1K 0.72% 33
2024
Q4
$840K Buy
+1,088
New +$901K 0.68% 30

Other funds holding LLY

Chancellor Financial Group WB's LLY Position: Q2 2026 in Review

Chancellor Financial Group WB increased its Eli Lilly (LLY) stake by 1.7% in Q2 2026, buying an estimated $15.3K and bringing the position to 918 shares worth $1.1M. The position accounts for 0.68% of the portfolio, ranked #31.

Chancellor Financial Group WB first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Chancellor Financial Group WB held 918 shares of Eli Lilly worth $1.1M as of Q2 2026.
  • Chancellor Financial Group WB bought 15 Eli Lilly shares in Q2 2026, an estimated $15.3K.
  • Eli Lilly made up 0.68% of Chancellor Financial Group WB's portfolio in Q2 2026, its #31 holding.
  • Chancellor Financial Group WB first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Chancellor Financial Group WB's 13F filing for Q2 2026, filed 10 Aug 2026.